Europe Respiratory Care Device Market

The Europe respiratory care devices market is projected to reach USD 8.96 billion by 2031 from USD 6.33 billion in 2026, at a CAGR of 7.2% during the forecast period. The main driver in the expansion of the Europe respiratory care devices market is the increasing prevalence of chronic respiratory diseases like COPD, asthma, and sleep apnea. The primary factors behind these diseases are the aging population, smoking, and rising air pollution levels across the region. Additionally, the rapidly growing elderly population in Europe is more vulnerable to respiratory disorders, leading to greater demand for oxygen therapy, ventilators, and monitoring devices for long-term use. Advances in technology, such as portable oxygen concentrators, smart inhalers, and connected ventilators, are also contributing by improving treatment outcomes and patient compliance, which encourages more extensive use. The shift toward home healthcare and remote patient monitoring further promotes device usage outside hospital settings. Moreover, a robust healthcare infrastructure, favorable reimbursement policies in many countries, and increased awareness of respiratory health following the COVID-19 pandemic are key factors supporting ongoing investments and the demand for advanced respiratory care technologies.

Some of the prominent players operating in the market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (USA), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), and other players.

To know about the assumptions considered for the study download the pdf brochure

The major companies in the market for Europe respiratory care devices are Koninklijke Philips N.V., Medtronic, ResMed Inc., Fisher & Paykel Healthcare Limited, and Drägerwerk AG & Co. KGaA. They are key players because of their highly diversified and technologically advanced product ranges, which include ventilators, CPAP/BiPAP systems, oxygen therapy devices, humidification solutions, and patient monitoring systems. Additionally, these companies enjoy high brand awareness, maintain strong and long-term collaborations with hospitals and home care providers across Europe, and have well-established distribution and service networks in the largest EU countries. By consistently investing in R&D, they can launch innovative, feature-rich, and user-friendly devices that align with the trends in home healthcare and remote monitoring. Moreover, they have gained customer trust and secured long-term contracts due to their ability to meet strict European regulatory and quality standards, along with providing excellent after-sales support and training programs. All these factors have contributed significantly to their competitive strength and market dominance in the region.

In September 2025, the broader collaboration between Masimo and Koninklijke Philips N.V. will combine their influence in the European respiratory care devices market through accelerated development and adoption of next-generation monitoring and respiratory solutions. The main goal of this partnership is to enable faster integration of cutting-edge sensor technologies and connected monitoring platforms into respiratory care systems, helping hospitals in Europe manage ventilation more effectively, improve patient safety and clinical efficiency, while aligning with the trend of smart, digitally enabled respiratory system care.

In March 2025, ResMed's brand evolution announcement marks an important milestone that strengthens its position in the European respiratory care devices market. The company has unified its product portfolio under the ResMed name, making the brand more recognizable to healthcare professionals and patients alike. This initiative aligns with the growing use of its sleep and respiratory therapies, especially in homecare and digital health sectors, and supports the expansion of connected breathing and sleep solutions across Europe markets.

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V. is a leading global health technology company based in the Netherlands. Philips has a history dating back to 1891 and a strong worldwide presence in medical equipment and healthcare solutions. In the European market for respiratory care devices, Philips is recognized for having one of the most extensive respiratory care portfolios available. Their products cover the entire patient journey, from highly sophisticated ventilators and capnography/monitoring solutions to home-based ventilation and sleep disordered breathing devices. Furthermore, these devices are often part of their overall patient monitoring and connected care platforms that integrate both hospital and home care settings. Philips owes much of its success in Europe to its long-standing partnership with healthcare institutions, not only in Western but also in Eastern Europe. This partnership has helped them gain significant knowledge of the technical aspects of interoperable and connected clinical systems, while continuously developing new solutions that align with local healthcare trends such as digital health and workflow efficiency. Additionally, Philips intentionally provides comprehensive post-sale training and support, enabling clinicians to maximize device use and improve clinical outcomes across intensive care units, emergency departments, and chronic care settings. By consistently investing in R&D and forming strategic alliances, the company overcomes both technological and regulatory barriers. As a result, Philips has become one of the leading manufacturers of respiratory monitoring and therapeutic devices in Europe.

Medtronic (Ireland)

Medtronic plc is one of the leading medical technology companies worldwide. Its headquarters are in Dublin, Ireland, but it operates in over 150 countries, with a significant portion of its business in the European healthcare market. The company is especially known for its acute care and patient monitoring respiratory care solutions used in hospital critical care environments, such as operating rooms, ICUs, and emergency departments. A key part of its respiratory device offerings in this area includes state-of-the-art capnography and respiratory monitoring products, particularly the Microstream CO monitoring systems, which are compatible with ventilators and multiparameter patient monitors. These systems enable real-time ventilation and patient status assessment, enhancing safety during anesthesia and critical care procedures. Medtronic's strong competition in Europe largely results from its longstanding partnerships with clinical hospitals and critical care facilities, its effective distribution channels, and its ongoing investment in R&D focused on improving the accuracy, connectivity, and seamless clinical integration of its products to meet Europe's high standards and regulations.

Market Ranking

The Europe respiratory care devices market is moderately consolidated, with Medtronic and Koninklijke Philips N.V. as the major leaders. They hold a large part of the market due to their dominance in ventilators, patient monitoring systems, and sleep therapy devices used in U.S. and Canadian hospitals and home care settings. Extensive hospital network contracts, integration of respiratory technologies into anesthesia workstations, ICUs, and connected care platforms, along with a wide range of established brands, enable these companies to be widely adopted. ResMed Inc. has a strong presence in the home respiratory care sector, especially in CPAP/BiPAP and cloud-connected sleep apnea solutions. Additionally, ResMed maintains solid partnerships with durable medical equipment (DME) suppliers and payers in the United States. Fisher & Paykel Healthcare Limited has become a leader in the hospital segment through its high-flow nasal cannula systems and humidification technologies, which are among the most frequently used in hospitals and neonatal care. Meanwhile, Drägerwerk AG & Co. KGaA has expanded its offerings with various respiratory care ventilators and anesthesia, as well as integrated solutions that are widely adopted by major healthcare networks. These manufacturers benefit from strong distribution networks, a steady flow of new products, and long-standing relationships with hospitals and home care providers, reinforcing their leadership in the Europe respiratory care market.

Related Reports:

Europe Respiratory Care Device Market Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings)- Regional Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]